Aclarion Inc.

NASDAQ: ACON · Real-Time Price · USD
6.58
0.10 (1.54%)
At close: Jun 02, 2025, 3:59 PM
6.42
-2.40%
After-hours: Jun 02, 2025, 07:33 PM EDT

Company Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States.

It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software.

The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.

Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Aclarion Inc.
Aclarion Inc. logo
Country United States
IPO Date Apr 22, 2022
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 5
CEO Brent Ness

Contact Details

Address:
951 Mariners Island Boulevard
Broomfield, California
United States
Website https://www.aclarion.com

Stock Details

Ticker Symbol ACON
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001450501
CUSIP Number 655187409
ISIN Number US6551872012
Employer ID 00-0000000
SIC Code

Key Executives

Name Position
Brent Ness Chief Executive Officer, President & Director
John Lorbiecki Chief Financial Officer
Dr. Jeffrey John Thramann M.D. Executive Chairman
Ryan Bond Chief Strategy Officer

Latest SEC Filings

Date Type Title
May 27, 2025 NPORT-P Filing
May 27, 2025 NPORT-P Filing
May 27, 2025 NPORT-P Filing
May 19, 2025 40-APP Filing
May 15, 2025 10-Q Quarterly Report
May 13, 2025 DEF 14A Filing
May 02, 2025 PRE 14A Filing
Apr 25, 2025 S-3 Filing
Apr 24, 2025 497 Filing
Apr 23, 2025 40-17G Filing